Literature DB >> 12818241

Proteoglycans of Wharton's jelly.

Tomasz Gogiel1, Edward Bańkowski, Stefan Jaworski.   

Abstract

Wharton's jelly (WJ) is a myxomatous substance surrounding the blood vessels of the umbilical cord. Proteoglycans (PGs) of Wharton's jelly have not been studied to date therefore it was decided to explore proteoglycan composition of this tissue. Proteoglycans were subjected to dissociative extraction with 4M guanidine hydrochloride containing Triton X-100 and protease inhibitors, purified by Q-Sepharose anion-exchange chromatography and lyophilised. They were analysed by gel filtration and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) before and after treatment with chondroitinase ABC. It was found that 1g of Wharton's jelly contains 2.43+/-0.63mg (n=10) of sulphated glycosaminoglycans (GAGs), reflecting the presence of proteoglycans. The proteoglycans were mainly substituted with chondroitin/dermatan sulphate (DS) chains. The predominant proteoglycan fraction included small proteoglycans with core proteins of 45 and 47kD, immunologically related to decorin (45 and 47kD) and biglycan (45kD). The expression of decorin core proteins was much higher than that of biglycan. Larger proteoglycans (core proteins of 90, 110, 220 and 260kD) were found in lower amounts. The most abundant of them (core protein of 260kD) was immunologically related to versican. Perlecan was not identified in Wharton's jelly. The study shows that Wharton's jelly contains mainly small chondroitin/dermatan sulphate proteoglycans, with decorin strongly predominating over biglycan. We suggest that an intensive expression of decorin is associated with very high content of its ligand, collagen.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12818241     DOI: 10.1016/s1357-2725(03)00128-6

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  18 in total

1.  Temperature-dependent ultrastructural changes in the cone interphotoreceptor matrix.

Authors:  Makoto Ishikawa; Toshiyuki Fujiwara; Takeshi Yoshitomi
Journal:  Jpn J Ophthalmol       Date:  2009-10-22       Impact factor: 2.447

2.  Development of a mechanically tuneable 3D scaffold for vascular reconstruction.

Authors:  Maritza Rodriguez; Cassandra Juran; Mark McClendon; Cyril Eyadiel; Peter S McFetridge
Journal:  J Biomed Mater Res A       Date:  2012-07-24       Impact factor: 4.396

3.  Determination of hyperelastic properties for umbilical artery in preeclampsia from uniaxial extension tests.

Authors:  R Blair Dodson; John T Martin; Kendall S Hunter; Virginia L Ferguson
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-03-31       Impact factor: 2.435

4.  ADAMTS9-Mediated Extracellular Matrix Dynamics Regulates Umbilical Cord Vascular Smooth Muscle Differentiation and Rotation.

Authors:  Sumeda Nandadasa; Courtney M Nelson; Suneel S Apte
Journal:  Cell Rep       Date:  2015-05-28       Impact factor: 9.423

5.  The molecular structure of human tissue type XV presents a unique conformation among the collagens.

Authors:  Jeanne C Myers; Peter S Amenta; Arnold S Dion; Justin P Sciancalepore; Chandrasekaran Nagaswami; John W Weisel; Peter D Yurchenco
Journal:  Biochem J       Date:  2007-06-15       Impact factor: 3.857

6.  A mouse model of spontaneous preterm birth based on the genetic ablation of biglycan and decorin.

Authors:  Megan L Calmus; Elyse E Macksoud; Richard Tucker; Renato V Iozzo; Beatrice E Lechner
Journal:  Reproduction       Date:  2011-04-18       Impact factor: 3.906

7.  Characterization of chondroitin sulfate and dermatan sulfate proteoglycans of extracellular matrices of human umbilical cord blood vessels and Wharton's jelly.

Authors:  Manojkumar Valiyaveettil; Rajeshwara N Achur; Arivalagan Muthusamy; D Channe Gowda
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

8.  Compensatory fetal membrane mechanisms between biglycan and decorin in inflammation.

Authors:  Luciana Batalha de Miranda de Araujo; Casie E Horgan; Abraham Aron; Renato V Iozzo; Beatrice E Lechner
Journal:  Mol Reprod Dev       Date:  2015-04-23       Impact factor: 2.609

9.  The human umbilical vein with Wharton's jelly as an allogeneic, acellular construct for vocal fold restoration.

Authors:  Roger W Chan; Maritza L Rodriguez; Peter S McFetridge
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

10.  Biglycan and decorin differentially regulate signaling in the fetal membranes.

Authors:  Zhiping Wu; Casie E Horgan; Olivia Carr; Rick T Owens; Renato V Iozzo; Beatrice E Lechner
Journal:  Matrix Biol       Date:  2013-12-25       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.